Paper
1,2-Bis(sulfonyl)hydrazines. 3. Effects of structural modification on antineoplastic activity.
Published Nov 1, 1987 · K. Shyam, R. T. Hrubiec, R. Furubayashi
Journal of medicinal chemistry
29
Citations
0
Influential Citations
Abstract
A series of 1,2-bis(sulfonyl)hydrazines was synthesized and evaluated for antineoplastic activity against the L1210 leukemia and the B16 melanoma. The most active agent to emerge from this study, 1,2-bis(methylsulfonyl)-1-methylhydrazine, produced a maximum % T/C for mice bearing the L1210 leukemia or the B16 melanoma of 340% and 278%, respectively. Two N-chloroethyl analogues, conceived as bifunctional alkylating agents, were also synthesized and evaluated for antineoplastic activity against the L1210 leukemia and the B16 melanoma. Although such a modification resulted in retention of antineoplastic activity against both tumor cell lines, it did not result in enhanced antineoplastic activity.
1,2-bis(methylsulfonyl)-1-methylhydrazine shows the most antineoplastic activity against L1210 leukemia and B16 melanoma, with retention of activity but not enhanced activity.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...